Literature DB >> 8414922

Beta adrenergic and muscarinic receptors in compensatory cardiac hypertrophy of the adult rat.

P Mansier1, B Chevalier, D B Barnett, B Swynghedauw.   

Abstract

The beta adrenergic (beta AR) and muscarinic (MR) receptors have been quantitated in parallel, using 125I-pindolol and 3H-quinuclidinylbenzilate, in a model of compensatory left ventricular (LV) hypertrophy (LVH), which developed in rats 4-6 weeks after an abdominal aortic stenosis. Since aortic banding resulted in a pronounced LVH of 62%, the results were expressed both in terms of density (fmol/mg protein) and quantity (fmol per LV). In addition, competition curves using either a specific beta 1-antagonist or isoproterenol or carbachol allowed the determination of the two beta AR subtypes and of the low and high affinity sites (defined by the inhibitory constant Ki) for both beta 1AR and MR. In LVH, receptor density decreased for each of total beta AR, beta 1AR subtype, high affinity (Ki 6-8 nM) beta 1AR sites (from 26 +/- 2 to 19 +/- 3 fmol/mg protein, P < 0.05), total MR and high affinity (Ki 12 nM) MR sites (from 63 +/- 6 to 40 +/- 4 fmol/mg protein, P < 0.001). The beta AR and MR densities dropped in parallel so that the MR/beta AR ratio remained unchanged. In sharp contrast (because the LVs were bigger) the quantities of total beta AR, beta 1AR subtype, beta 1AR high affinity sites, total MR and MR high affinity sites per LV were unmodified.(ABSTRACT TRUNCATED AT 250 WORDS)

Entities:  

Mesh:

Substances:

Year:  1993        PMID: 8414922     DOI: 10.1007/bf00384363

Source DB:  PubMed          Journal:  Pflugers Arch        ISSN: 0031-6768            Impact factor:   3.657


  34 in total

Review 1.  Beta 1- and beta 2-adrenoceptors in the human heart: properties, function, and alterations in chronic heart failure.

Authors:  O E Brodde
Journal:  Pharmacol Rev       Date:  1991-06       Impact factor: 25.468

2.  Improvement of cholera toxin-catalyzed ADP-ribosylation by endogenous ADP-ribosylation factor from bovine brain provides evidence for an unchanged amount of Gs alpha in failing human myocardium.

Authors:  P Schnabel; M Böhm; P Gierschik; K H Jakobs; E Erdmann
Journal:  J Mol Cell Cardiol       Date:  1990-01       Impact factor: 5.000

Review 3.  G protein involvement in receptor-effector coupling.

Authors:  P J Casey; A G Gilman
Journal:  J Biol Chem       Date:  1988-02-25       Impact factor: 5.157

4.  Beta 1- and beta 2-adrenergic-receptor subpopulations in nonfailing and failing human ventricular myocardium: coupling of both receptor subtypes to muscle contraction and selective beta 1-receptor down-regulation in heart failure.

Authors:  M R Bristow; R Ginsburg; V Umans; M Fowler; W Minobe; R Rasmussen; P Zera; R Menlove; P Shah; S Jamieson
Journal:  Circ Res       Date:  1986-09       Impact factor: 17.367

5.  Cardiac muscarinic cholinergic receptors. Biochemical identification and characterization.

Authors:  J Z Fields; W R Roeske; E Morkin; H I Yamamura
Journal:  J Biol Chem       Date:  1978-05-10       Impact factor: 5.157

6.  Beta-adrenergic system is modified in compensatory pressure cardiac overload in rats: physiological and biochemical evidence.

Authors:  B Chevalier; P Mansier; F Callens-el Amrani; B Swynghedauw
Journal:  J Cardiovasc Pharmacol       Date:  1989-03       Impact factor: 3.105

7.  Increased number of beta-adrenergic receptors in the hypertrophied myocardium.

Authors:  C J Limas
Journal:  Biochim Biophys Acta       Date:  1979-11-15

8.  Renin-angiotensin system involvement in pressure-overload cardiac hypertrophy in rats.

Authors:  K M Baker; M I Chernin; S K Wixson; J F Aceto
Journal:  Am J Physiol       Date:  1990-08

Review 9.  Protein turnover during skeletal muscle hypertrophy.

Authors:  G J Laurent; D J Millward
Journal:  Fed Proc       Date:  1980-01

10.  Beta-adrenergic receptors in rat myocardium during the development and reversal of hypertrophy and following chronic infusions of angiotensin II and epinephrine.

Authors:  M E Upsher; P A Khairallah
Journal:  Arch Int Pharmacodyn Ther       Date:  1985-03
View more
  4 in total

1.  Adrenomedullin upregulates M2-muscarinic receptors in cardiomyocytes from P19 cell line.

Authors:  Sophie Buys; Fatima Smih; Atul Pathak; Pierre Philip-Couderc; Patrick Verwaerde; Jean-Louis Montastruc; Philippe Rouet; Jean-Michel Senard
Journal:  Br J Pharmacol       Date:  2003-07       Impact factor: 8.739

2.  Calcium channels and cation transport ATPases in cardiac hypertrophy induced by aortic constriction in newborn rats.

Authors:  L Zheng; M Wibo; F Kolár; T Godfraind
Journal:  Mol Cell Biochem       Date:  1996 Oct-Nov       Impact factor: 3.396

3.  Decreased expression and activity of cAMP phosphodiesterases in cardiac hypertrophy and its impact on beta-adrenergic cAMP signals.

Authors:  Aniella Abi-Gerges; Wito Richter; Florence Lefebvre; Philippe Mateo; Audrey Varin; Christophe Heymes; Jane-Lise Samuel; Claire Lugnier; Marco Conti; Rodolphe Fischmeister; Grégoire Vandecasteele
Journal:  Circ Res       Date:  2009-09-10       Impact factor: 17.367

4.  Noninvasive assessment of autonomic modulation of heart rate variability in the Ts65Dn mouse model of Down syndrome: A proof of principle study.

Authors:  Adriano L Roque; Mark W Johnson; Melissa R Stasko; Luiz C de Abreu; Talita D da Silva; Alberto C S Costa
Journal:  Physiol Rep       Date:  2020-06
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.